Glyciphage-VG 2mg/500mg/0.2mg Tablet SR
Marketer
Franco-Indian Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glyciphage-VG 2mg/500mg/0.2mg Tablet SR
Diabetic patients (adult Type 2) may find Metformin/Voglibose/Pioglitazone SR tablets (2mg/500mg/0.2mg) beneficial in managing their blood glucose. This triple-combination medication regulates blood sugar, administered orally with meals, consistently at the same time daily. Dosage is determined by your physician and adjusted based on your glycemic response. Continuous use, even with controlled blood sugar, is vital. Abrupt cessation can cause dangerously elevated blood glucose, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic diabetes management plan, incorporating diet, exercise, and weight control as directed by your healthcare provider. Hypoglycemia (low blood sugar) is a frequent adverse effect, manifested by sweating, dizziness, headache, and tremors. Prompt glucose ingestion (e.g., sugary foods, juice) is crucial. Alcohol should be avoided as it heightens hypoglycemia risk. Additional side effects may encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, visual blurring, fractures, and upper respiratory infections. Weight gain is a potential consequence. This medication is contraindicated for Type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Pre-existing heart conditions should be disclosed to your doctor before commencing treatment. Consult your physician before use if pregnant or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests (complete blood count and liver function), are recommended.
Uses of Glyciphage-VG 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glyciphage-VG 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyciphage-VG 2mg/500mg/0.2mg Extended-Release tablets should be taken on an empty stomach.
Common Side effects of Glyciphage-VG 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glyciphage-VG 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glyciphage-VG 2mg/500mg/0.2mg SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
How Glyciphage-VG 2mg/500mg/0.2mg Tablet SR works:
Metformin, glimepiride, and voglibose are combined in the extended-release Glyciphage-VG 2mg/500mg/0.2mg tablet to manage blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Glyciphage-VG 2mg/500mg/0.2mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Using Glyciphage-VG 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glyciphage-VG 2mg/500mg/0.2mg tablet is likely not safe for breastfeeding mothers. Available data in humans indicate potential transfer to breast milk with possible infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Metformin/glimepiride/pioglitazone extended-release tablets (2mg/500mg/0.2mg) pose a likely risk for individuals with impaired renal function and should be omitted. Medical advice is necessary. Furthermore, this medication is unsuitable for patients exhibiting severe kidney disease.
LiverCAUTION
Individuals with liver impairment should use Glyciphage-VG 2mg/500mg/0.2mg SR tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Glyciphage-VG 2mg/500mg/0.2mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glyciphage-VG 2mg/500mg/0.2mg Tablet SR :
Should you forget a Glyciphage-VG 2mg/500mg/0.2mg Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glyciphage-VG 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently